Depression, anxiety, and suicidal ideation in adults with COVID‐induced parosmia-Reference-Cited by-同舟云学术

Depression, anxiety, and suicidal ideation in adults with COVID‐induced parosmia

Published:2023-07-05 Issue:12 Volume:13 Page:2240-2243
ISSN:2042-6976
Container-title:International Forum of Allergy & Rhinology
language:en
Short-container-title:Int Forum Allergy Rhinol

Author:

Stoller Emily¹,Hentati Firas²³^ORCID,Kallogjeri Dorina³,Piccirillo Jay F.³,Lenze Eric J.⁴,Farrell Nyssa Fox⁵^ORCID

Affiliation:

1. Washington University in St. Louis St. Louis Missouri USA

2. Case Western Reserve University School of Medicine Cleveland Ohio USA

3. Clinical Outcomes Research Office, Department of Otolaryngology–Head & Neck Surgery Washington University in St. Louis School of Medicine St. Louis Missouri USA

4. Department of Psychiatry Washington University in St. Louis School of Medicine St. Louis Missouri USA

5. Division of Rhinology Department of Otolaryngology–Head & Neck Surgery Washington University in St. Louis School of Medicine St. Louis Missouri USA

Abstract

KEY POINTS

COVID‐induced parosmia is associated with anxiety, depression, and suicidal ideation.

Parosmic patients have low rates of treatment benefit and little hope for improvement.

Hyposmia may mitigate the quality‐of‐life burden in patients with parosmia.

Publisher

Wiley

Subject

Otorhinolaryngology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alr.23211

Reference10 articles.

1. Parosmia is prevalent and persistent amongst those with COVID‐19 olfactory dysfunction;Cook E;Rhinology,2021

2. Parosmia in patients with COVID‐19 and olfactory dysfunction

3. Clinical factors associated with lower health scores in COVID‐19–related persistent olfactory dysfunction

4. Early Parosmia Signs and Affective States Predict Depression and Anxiety Symptoms 6 Months After a Mild Traumatic Brain Injury

5. Olfactory Disorders and Quality of Life--An Updated Review